C James Watson1,2, Michael Ganetsky3, Ryan C Burke3, Yotam Dizitzer4, Evan L Leventhal3, Katherine L Boyle3. 1. Department of Emergency Medicine, Beth Israel Deaconess Medical Center, 1 Deaconess Road, 2nd Floor, Boston, MA, 02215, USA. cjwatson@bidmc.harvard.edu. 2. Harvard Medical Toxicology Program, Boston Children's Hospital, Boston, MA, USA. cjwatson@bidmc.harvard.edu. 3. Department of Emergency Medicine, Beth Israel Deaconess Medical Center, 1 Deaconess Road, 2nd Floor, Boston, MA, 02215, USA. 4. Clinical Research Center, Soroka University Medical Center, Beer-Sheba, Israel.
Abstract
BACKGROUND: Prescription drug monitoring programs (PDMPs) exist in 49 states to guide opioid prescribing. In 40 states, clinicians must check the PDMP prior to prescribing an opioid. Data on mandated PDMP checks show mixed results on opioid prescribing. OBJECTIVES: This study sought to examine the impact of the Massachusetts mandatory PDMP check on opioid prescribing for discharges from an urban tertiary emergency department (ED). METHODS: This was a retrospective cohort study of discharges from one ED from 7/1/2010-10/15/2018. The primary outcome was the monthly percentage of patients discharged from the ED with an opioid prescription. The intervention was Massachusetts mandating a PDMP check for all opioid prescriptions. Prescribing was compared pre- and post-mandate. Interrupted time series (ITS) analysis accounted for known declining trends in opioid prescribing. RESULTS: Of 273,512 ED discharges, 35,050 (12.8%) received opioid prescriptions. Mean monthly opioid prescribing decreased post-intervention from 15.1% (SD ± 3.5%) to 5.1% (SD ± 0.9%; p < 0.001). ITS showed equal pre and post-intervention slopes (-0.002, p = 0.819). A small immediate decrease occurred in prescribing around the mandated check: a 3-month level effect decrease of 0.018 (p = 0.039), 6-month level effect 0.019 (p = 0.023), and a 12-month level effect of 0.020 (p = 0.019). The 24-month level effect was not decreased. CONCLUSION: Prior to the mandated PDMP check, ED opioid prescribing was declining. The mandate did not change the rate of decline but was associated with a non-sustained drop in opioid prescribing immediately following enactment.
BACKGROUND: Prescription drug monitoring programs (PDMPs) exist in 49 states to guide opioid prescribing. In 40 states, clinicians must check the PDMP prior to prescribing an opioid. Data on mandated PDMP checks show mixed results on opioid prescribing. OBJECTIVES: This study sought to examine the impact of the Massachusetts mandatory PDMP check on opioid prescribing for discharges from an urban tertiary emergency department (ED). METHODS: This was a retrospective cohort study of discharges from one ED from 7/1/2010-10/15/2018. The primary outcome was the monthly percentage of patients discharged from the ED with an opioid prescription. The intervention was Massachusetts mandating a PDMP check for all opioid prescriptions. Prescribing was compared pre- and post-mandate. Interrupted time series (ITS) analysis accounted for known declining trends in opioid prescribing. RESULTS: Of 273,512 ED discharges, 35,050 (12.8%) received opioid prescriptions. Mean monthly opioid prescribing decreased post-intervention from 15.1% (SD ± 3.5%) to 5.1% (SD ± 0.9%; p < 0.001). ITS showed equal pre and post-intervention slopes (-0.002, p = 0.819). A small immediate decrease occurred in prescribing around the mandated check: a 3-month level effect decrease of 0.018 (p = 0.039), 6-month level effect 0.019 (p = 0.023), and a 12-month level effect of 0.020 (p = 0.019). The 24-month level effect was not decreased. CONCLUSION: Prior to the mandated PDMP check, ED opioid prescribing was declining. The mandate did not change the rate of decline but was associated with a non-sustained drop in opioid prescribing immediately following enactment.
Entities:
Keywords:
Emergency department; Opioid; Prescription drug monitoring program
Authors: Scott G Weiner; Olesya Baker; Sabrina J Poon; Ann F Rodgers; Chad Garner; Lewis S Nelson; Jeremiah D Schuur Journal: Ann Emerg Med Date: 2017-05-23 Impact factor: 5.721
Authors: Hilary L Surratt; Catherine O'Grady; Steven P Kurtz; Yamilka Stivers; Theodore J Cicero; Richard C Dart; Minxing Chen Journal: Pharmacoepidemiol Drug Saf Date: 2014-03 Impact factor: 2.890
Authors: Macarena C García; Anton B Dodek; Tom Kowalski; John Fallon; Scott H Lee; Michael F Iademarco; John Auerbach; Michele K Bohm Journal: MMWR Morb Mortal Wkly Rep Date: 2016-10-21 Impact factor: 17.586
Authors: Ellen Meara; Jill R Horwitz; Wilson Powell; Lynn McClelland; Weiping Zhou; A James O'Malley; Nancy E Morden Journal: N Engl J Med Date: 2016-06-22 Impact factor: 91.245
Authors: Benjamin C Sun; Christina J Charlesworth; Nicoleta Lupulescu-Mann; Jenny I Young; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell Journal: Ann Emerg Med Date: 2017-12-13 Impact factor: 5.721